Improved one-step micro-lymphocytotoxicity cross-over trial.docVIP

Improved one-step micro-lymphocytotoxicity cross-over trial.doc

  1. 1、本文档共5页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Improved one-step micro-lymphocytotoxicity cross-over trial

 PAGE \* MERGEFORMAT 5 Improved one-step micro-lymphocytotoxicity cross-over trial Lymphocytotoxicity cross-over trial, also known as complement-dependent cytotoxicity test (CDC). It is to check whether the body organ transplant recipients for the donor or donors for the recipient’s HLA antibodies in organ transplant must be carried out before the CDC test. If detected by the serum against the donor’s HLA antibodies, is generally considered taboo with transplant recipients occur after the hyperacute rejection, leading to graft failure. As the pilot implementation of an organ transplant operation in the interim before the match of the test results of the report requested in a short time, so we made an improvement of the technology compared with the traditional method, you receive satisfactory results. Are reported as follows: One, materials and methods 1. Was seized object: specimens from the past 10 months in our hospital inpatient and outpatient 280 cases of renal transplantation to be done to be medical consultation and other organ transplants to be patients attending who do not adopt 2 ml blood anticoagulant under test. 2. Reagent: Immunization beads, fluorescent dye liquor OL provided by the United States, anti-lymphocyte antibody reagents all purchased from Wuhan Institute of Biological Products. 3. Methods: (1) Improvement step: use of immunomagnetic beads 3 ~ 5 μ l isolated lymphocytes, in the Terasaki plate sterile mineral oil per well by adding 5 μ l, each row of the first one-hole plus 1 μ l saline so negative contrast, the first two holes plus 1 μ l of anti-lymphocyte antibody-wide to do positive control, 3 to 6 holes of various increases in serum by 1 μ l (ie repeat the 4-hole tests), each hole for each category of donor lymphocytes in 1 μ l (cell concentration 2 000 / μ l), each well complement each plus 1 μ l, home 22 ~ 25 ℃ room temperature for about 45 min reaction, each well add fluorescent dye liquor 5 μ l, the cells were observe

文档评论(0)

hhuiws1482 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:5024214302000003

1亿VIP精品文档

相关文档